Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 3/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 6/20 | 0.41 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.41 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.40 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.38 |
| ▸ | CTSB | P07858 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23039739 | 0.91 | CTSL (0.41) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| SCHEMBL869115 | 0.91 | CTSL (0.41) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| SCHEMBL379081 | 0.91 | CTSL (0.41) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| SCHEMBL29101108 | 0.91 | CTSL (0.41) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| SCHEMBL16239892 | 0.91 | CTSL (0.41) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| Methyl Alcohol SCHEMBL17513807 | 0.89 | LMNA (0.42) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| Methyl Alcohol SCHEMBL16210946 | 0.89 | LMNA (0.42) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| SCHEMBL20531 | 0.88 | CTSL (0.38) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| Methyl Alcohol SCHEMBL3273946 | 0.86 | LMNA (0.39) | SLC1A3SLC1A2SLC1A1LMNASPHK1 | |
| SCHEMBL29142423 | 0.85 | CTSL (0.37) | SLC1A3SLC1A2SLC1A1LMNASPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0558570-B1 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS | SCHERING AG (DE) | 1996-01-10 | — | — | EP | disclosed |
| EP-0558570-A1 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS. | SCHERING AG (DE) | 1993-09-08 | — | — | EP | disclosed |
| WO-1992009573-A2 | CYCLOPENTANE ETHER DERIVATIVES, METHODS FOR PREPARING THEM AND THEIR USE IN PHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) | 1992-06-11 | — | — | WO | disclosed |